Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
In oncology, prognostic markers are clinical measures used to help elicit an individual patient's risk of a future outcome, such as recurrence of disease after primary treatment. They thus facilitate individual treatment choice and aid in patient counselling. Evidence-based results regarding pr...
Main Authors: | Riley, R, Sauerbrei, W, Altman, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Evidence-based assessment and application of prognostic markers: The long way from single studies to meta-analysis
by: Sauerbrei, W, et al.
Published: (2006) -
Primer: an evidence-based approach to prognostic markers.
by: Altman, D, et al.
Published: (2005) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
by: Mallett, S, et al.
Published: (2010) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
by: Mallett, S, et al.
Published: (2010) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
by: Altman, D, et al.
Published: (2012)